Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0NDNJB
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
TARG-10
|
|||||
| Synonyms |
TARG 10; TARG10
Click to Show/Hide
|
|||||
| Organization |
Cartela AB; Hansa Biopharma AB; Uppsala universitet Holding AB; BioInvent International AB; Redwood Bioscience, Inc.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 2 Indication(s)
Glioblastoma [ICD11:2A00]
Clinical candidate
Metastatic breast cancer [ICD11:2C6Y]
Clinical candidate
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Integrin alpha-10 (ITGA10)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.